Author： Matthias von Herrath Rottembourg Diane Bresson Damien
Publisher： Adis International
ISSN： 1173-8804
Source： BioDrugs, Vol.20, Iss.6, 2006-01, pp. : 341-350
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus: Potential for Immunotherapy
BioDrugs, Vol. 15, Iss. 5, 2001-05 ,pp. :
Access to resources
Recommend
Incretin-Based Therapies in Patients with Type 2 Diabetes
Current Drug Therapy, Vol. 5, Iss. 2, 2010-05 ,pp. :
Iliopsoas abscess in adolescents with type 1 diabetes mellitus
Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. :
Spotlight on Insulin Detemir in Type 1 and 2 Diabetes Mellitus
By Chapman Therese M. Perry Caroline M.
BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. :
Long-Acting GLP-1 Analogs for the Treatment of Type 2 Diabetes Mellitus
By Vilsbøll Tina Knop Filip K.
BioDrugs, Vol. 22, Iss. 4, 2008-01 ,pp. :